282 related articles for article (PubMed ID: 26022453)
1. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
[TBL] [Abstract][Full Text] [Related]
2. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma.
Cimino PJ; Robirds DH; Tripp SR; Pfeifer JD; Abel HJ; Duncavage EJ
Mod Pathol; 2014 Aug; 27(8):1073-87. PubMed ID: 24406863
[TBL] [Abstract][Full Text] [Related]
4. Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors.
Lai JH; Fleming KE; Ly TY; Pasternak S; Godlewski M; Doucette S; Walsh NM
Hum Pathol; 2015 Sep; 46(9):1290-6. PubMed ID: 26099430
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profiles of different subsets of Merkel cell carcinoma.
Pasternak S; Carter MD; Ly TY; Doucette S; Walsh NM
Hum Pathol; 2018 Dec; 82():232-238. PubMed ID: 30067951
[TBL] [Abstract][Full Text] [Related]
6. Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors.
Busam KJ; Pulitzer MP; Coit DC; Arcila M; Leng D; Jungbluth AA; Wiesner T
Mod Pathol; 2017 Jun; 30(6):877-883. PubMed ID: 28281550
[TBL] [Abstract][Full Text] [Related]
7. Oral cavity neuroendocrine carcinoma: a comparison study with cutaneous Merkel cell carcinoma and other mucosal head and neck neuroendocrine carcinomas.
Lewis JS; Duncavage E; Klonowski PW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):209-17. PubMed ID: 20659699
[TBL] [Abstract][Full Text] [Related]
8. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas.
Asioli S; Righi A; de Biase D; Morandi L; Caliendo V; Picciotto F; Macripò G; Maletta F; di Cantogno LV; Chiusa L; Eusebi V; Bussolati G
Mod Pathol; 2011 Nov; 24(11):1451-61. PubMed ID: 21765392
[TBL] [Abstract][Full Text] [Related]
9. Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases.
Narisawa Y; Koba S; Inoue T; Nagase K
J Dermatol; 2015 May; 42(5):445-52. PubMed ID: 25720654
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.
Busam KJ; Jungbluth AA; Rekthman N; Coit D; Pulitzer M; Bini J; Arora R; Hanson NC; Tassello JA; Frosina D; Moore P; Chang Y
Am J Surg Pathol; 2009 Sep; 33(9):1378-85. PubMed ID: 19609205
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
[TBL] [Abstract][Full Text] [Related]
12. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
[TBL] [Abstract][Full Text] [Related]
13. TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.
Czapiewski P; Majewska H; Kutzner H; Kazakov D; Renkielska A; Biernat W
Am J Dermatopathol; 2016 Jul; 38(7):513-6. PubMed ID: 27322785
[TBL] [Abstract][Full Text] [Related]
14. Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal.
DeCoste RC; Carter MD; Pasternak S; Fleming KE; Gaston D; Legge A; Ly TY; Walsh NM
Hum Pathol; 2021 Nov; 117():31-41. PubMed ID: 34391748
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma.
Stanoszek LM; Chan MP; Palanisamy N; Carskadon S; Siddiqui J; Patel RM; Harms KL; Lowe L; Fullen DR; Harms PW
Histopathology; 2019 Feb; 74(3):504-513. PubMed ID: 30239030
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
17. Genetic profiles of different subsets of Merkel cell carcinoma show links between combined and pure MCPyV-negative tumors.
Carter MD; Gaston D; Huang WY; Greer WL; Pasternak S; Ly TY; Walsh NM
Hum Pathol; 2018 Jan; 71():117-125. PubMed ID: 29079179
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
Chan JK; Suster S; Wenig BM; Tsang WY; Chan JB; Lau AL
Am J Surg Pathol; 1997 Feb; 21(2):226-34. PubMed ID: 9042291
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas.
Kervarrec T; Tallet A; Miquelestorena-Standley E; Houben R; Schrama D; Gambichler T; Berthon P; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Tabareau-Delalande F; Beneton N; Fromont G; Arbion F; Leteurtre E; Touzé A; Samimi M; Guyétant S
Mod Pathol; 2019 Apr; 32(4):499-510. PubMed ID: 30349028
[TBL] [Abstract][Full Text] [Related]
20. Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.
González-Vela MDC; Curiel-Olmo S; Derdak S; Beltran S; Santibañez M; Martínez N; Castillo-Trujillo A; Gut M; Sánchez-Pacheco R; Almaraz C; Cereceda L; Llombart B; Agraz-Doblas A; Revert-Arce J; López Guerrero JA; Mollejo M; Marrón PI; Ortiz-Romero P; Fernandez-Cuesta L; Varela I; Gut I; Cerroni L; Piris MÁ; Vaqué JP
J Invest Dermatol; 2017 Jan; 137(1):197-206. PubMed ID: 27592799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
